Study: Many cancer drugs unproven 5 years after accelerated approval
Time:2024-05-21 09:19:37 Source:businessViews(143)
The U.S. Food and Drug Administration’s accelerated approval program is meant to give patients early access to promising drugs. But how often do these drugs actually improve or extend patients’ lives?
In a new study, researchers found that most cancer drugs granted accelerated approval do not demonstrate such benefits within five years.
“Five years after the initial accelerated approval, you should have a definitive answer,” said Dr. Ezekiel Emanuel, a cancer specialist and bioethicist at the University of Pennsylvania who was not involved in the research. “Thousands of people are getting those drugs. That seems a mistake if we don’t know whether they work or not.”
The program was created in 1992 to speed access to HIV drugs. Today, 85% of accelerated approvals go to cancer drugs.
It allows the FDA to grant early approval to drugs that show promising initial results for treating debilitating or fatal diseases. In exchange, drug companies are expected to do rigorous testing and produce better evidence before gaining full approval.
Previous:Here comes the char
Next:Ohio judge to rule Monday on whether the state’s abortion ban stands
You may also like
- Young Boys seals 6th Swiss soccer league title in 7 years after rallying from firing coach Wicky
- UN chief calls for reform of global financial architecture, particularly with regard to debt
- Days Of Our Lives sees THREE old faces from the 1980s RETURN
- George Soros drops $60 MILLION into Democrats' war chest
- Investigators return to Long Island home of Gilgo Beach serial killing suspect
- Katie Couric tells Bill Maher that Trump support is born out of 'anti
- Pamela Anderson lands starring role in The Naked Gun reboot alongside Liam Neeson
- Russian air defense forces neutralize over 30,000 Ukrainian aerial weapons
- Brazil replaces injured goalkeeper Ederson in Copa America squad